BIOVEST INTERNATIONAL, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • February 21st, 2006 • Biovest International Inc • Pharmaceutical preparations • New York
This Incentive Stock Option Agreement (this “Agreement”) is effective as of February 10, 2006, (the “Option Grant Date”) between BIOVEST INTERNATIONAL, INC., a Delaware corporation (the “Company”), and David Moser (the “Optionee”).
THE INVESTOR RELATIONS GROUP INC. LETTER OF AGREEMENT Date: January 7, 2006Letter of Agreement • February 21st, 2006 • Biovest International Inc • Pharmaceutical preparations • New York
October 27, 2005 Stephane Allard, M.D. Englewood, NJ 07631Biovest International Inc • February 21st, 2006 • Pharmaceutical preparations • New Jersey
This letter agreement sets forth the terms of a settlement resolving all outstanding issues, compensation, contractual rights and entitlements of any nature including but not limited to rights to severance and other compensation and all other rights or claims arising from all current and past employment agreements and relationships of Stephane Allard (“Employee”) with: (i) Accentia Biopharmaceuticals, Inc. (“Accentia”), (ii) all subsidiaries of Accentia, and (iii) Biovest International, Inc. (“Biovest”); Accentia, all Accentia Subsidiaries, and Biovest are collectively referred to at times herein as the “Entities”.
Biovest International, Inc. EMPLOYMENT AGREEMENTEmployment Agreement • February 21st, 2006 • Biovest International Inc • Pharmaceutical preparations • Florida
THIS EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into as of this 1st day of January, 2006, by and between Biovest International, Inc. (the “Company”) and (“Employee”).
Plaintiff, -against- COMPROMISE AND SETTLEMENT AGREEMENTSettlement Agreement • February 21st, 2006 • Biovest International Inc • Pharmaceutical preparations • New York
IT IS HEREBY STIPULATED AND AGREED, by and between the undersigned counsel for plaintiff Dr. Robert D. Pfeffer (hereinafter “Pfeffer”) and defendant, Biovest International, Inc. (hereinafter “Biovest”), as follows:
